Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Embolization of the Splenic Artery After Trauma (ELSA-2)

NCT05128955 is registered in ClinicalTrials.gov with Andrew J. Gunn as lead sponsor.

NCT NCT05128955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05128955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Embolization of the Splenic Artery After Trauma (ELSA-2)
Lead sponsor
Andrew J. Gunn
Phase
Not applicable
Overall status
Completed
Start date
May 10, 2022
Completion date
April 22, 2026
Enrollment
180 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

high-grade splenic injuries